Herbalife Ltd. (HLF) Stock Price & Analysis
Herbalife Ltd. (HLF) is trading at USD 13.23, down 3.99% today, as of October 23, 2026 at 16:58 UTC (US market open; quotes may be delayed), according to Nexqual market data.
HLF last closed at USD 13.78; today's session has ranged USD 13.21–13.76 on volume of 441,314 shares. Market capitalization is $1.37B, with a 52-week range of USD 7.56–20.4 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 17:00 UTC.
Also available as compact Markdown for AI agents: nexqual.com/HLF.md
Key facts (HLF)
- Last four reported quarters (through Jun 30, 2026): revenue $5.20B, net income $164M (3.2% margin), free cash flow $322M (SEC filings).
- Valuation: P/E 8.4x (avg 6.4x at the last 3 fiscal year-ends), EV/EBITDA 4.9x, net debt $1.65B.
- 1 of 80 tracked superinvestors hold HLF (13F, Q2 2026): 0 new, 0 added, 0 reduced, 1 unchanged.
- Insider open-market sales, last ~7 months: 2 Form 4 filings, $2.6M; 2 not under a Rule 10b5-1 plan ($2.6M); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Insider open-market purchases, last ~7 months: 1 Form 4 filing, $14K; 0 by opportunistic insiders, 0 by routine insiders.
- Analysts: Hold (mean 2.50 on a 1–5 scale) (4 analysts), mean target USD 17 (range 9–25).
- Total return with dividends: 1Y +55.5% vs S&P 500 +14.6%; 5Y -71.5% vs S&P 500 +77.3%.
- Next earnings: 2026-11-02, EPS estimate USD 0.62, revenue estimate $1.31B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (HLF)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $5.80B | $5.20B | $5.06B | $4.99B | $5.04B | $5.20B |
| Gross profit | $4.56B | $4.03B | $3.87B | $3.89B | $3.92B | — |
| Operating income | $734M | $545M | $356M | $386M | $481M | $492M |
| Net income | $447M | $321M | $142M | $254M | $228M | $164M |
| EPS (diluted) | $4.13 | $3.23 | $1.42 | $2.50 | $2.20 | — |
| Free cash flow | $309M | $196M | $223M | $163M | $253M | $322M |
| Gross margin | 78.6% | 77.4% | 76.5% | 77.9% | 77.9% | — |
| Operating margin | 12.7% | 10.5% | 7.0% | 7.7% | 9.5% | 9.5% |
| Net margin | 7.7% | 6.2% | 2.8% | 5.1% | 4.5% | 3.2% |
| Revenue growth | +4.7% | -10.3% | -2.7% | -1.4% | +0.9% | — |
| Cash + short-term investments | $602M | $508M | $575M | $415M | $353M | — |
| Total debt | $2.76B | $2.69B | $2.56B | $2.26B | $1.99B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (HLF)
P/E 8.4x · P/S 0.3x · EV/EBITDA 4.9x · EV/Sales 0.6x · P/FCF 4.3x · FCF yield 23.50% · Earnings yield 11.97% · Buyback yield (TTM) 0.83% · Net debt $1.65B · EV $3.02B
P/E at fiscal year-ends: Dec 2025 5.8x, Dec 2024 2.7x, Dec 2023 10.8x.
Superinvestors (SEC 13F-HR, Q2 2026) (HLF)
1 of 80 tracked investors hold HLF. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Seth Klarman | Baupost Group | 2.25% | $122M | Unchanged |
Insider sales (SEC Form 4, open-market, last ~7 months) (HLF)
0 of 2 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-05-18…2026-05-19 | Hicks Troy | Chief Operating Officer | 48,377 | $620K | 83.3% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-05-11…2026-05-12 | Lamberti Frank | Chief Commercial Officer | 142,919 | $1.9M | 79.6% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.
Insider purchases (SEC Form 4, open-market, last ~7 months) (HLF)
1 purchase, $14K. Private placements, offerings, dividend reinvestment and employee stock purchase plan buys are excluded.
| Trade date | Insider | Role | Shares | Value | Avg price | Insider type |
|---|---|---|---|---|---|---|
| 2026-06-04 | L'Helias Sophie | Director | 1,200 | $14K | 11.31 | Too little history (no open-market trades in 2024) |
Analysts (HLF)
Consensus Hold (mean 2.50 on a 1–5 scale), 4 analysts; mean target USD 17 (low 9, high 25).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-07 | Citigroup | Target lowered | Buy | $21 → $17 |
Total return (dividends reinvested) (HLF)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +55.5% | -71.5% |
| S&P 500 (SPY) | +14.6% | +77.3% |
| Per year | +55.5% | -22.2% |
| Volatility (annualized) | 58.3% | 60.7% |
| Max drawdown | -44.9% (Feb 2026→Aug 2026) | -88.5% (Oct 2021→Feb 2025) |
HLF revenue by product line (fiscal year ended Dec 31, 2025)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Weight Management | $2.75B | 54.5% | -0.8% |
| Targeted Nutrition | $1.51B | 30.0% | +1.7% |
| Energy Sports & Fitness | $617.1M | 12.3% | +7.8% |
| Outer Nutrition | $85.0M | 1.7% | +1.7% |
| Literature Promotional & Other | $79.1M | 1.6% | -6.8% |
| Total revenue | $5.04B | 100% | — |
HLF revenue by region (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Primary Reporting | $1.27B | 95.4% | +7.4% |
| — Others (part of Primary Reporting) | $503.9M | 38.0% | -1.7% |
| — India (part of Primary Reporting) | $270.6M | 20.4% | +32.9% |
| — United States (part of Primary Reporting) | $266.3M | 20.1% | +0.4% |
| — Mexico (part of Primary Reporting) | $161.0M | 12.1% | +17.3% |
| — Vietnam (part of Primary Reporting) | $64.6M | 4.9% | +7.3% |
| China | $60.4M | 4.6% | -24.5% |
| Total revenue | $1.33B | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
HLF suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | Pro2col | “In July 2025, at the North America Extravaganza, we unveiled the beta version of the new Pro2col health and wellness digital platform, that will allow customers in the future to have access to more product offerings in addition to being able to access this health and wellness digital application.” |
Quoted from the company's 10-K filed Feb 18, 2026.
HLF analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.62 | $0.70 | -11.2% | $1.31B | 2 |
| Next quarter (ends Dec 2026) | $0.61 | $0.69 | -11.8% | $1.31B | 2 |
| Current fiscal year (ends Dec 2026) | $2.37 | $2.64 | -10.4% | $5.26B | 2 |
| Next fiscal year (ends Dec 2027) | $3.08 | $3.15 | -2.4% | $5.39B | 2 |
Key Statistics (as of October 23, 2026 at 17:00 UTC)
| Price | USD 13.23 |
|---|---|
| Change | ▼ 3.99% (down) |
| Previous Close | USD 13.78 |
| Open | USD 13.6 |
| Day Range | USD 13.21 – 13.76 |
| 52-Week Range | USD 7.56 – 20.4 |
| Volume | 441,314 shares |
| Market Cap | $1.37B |
| Exchange | NYQ |
Technical Analysis (HLF)
Nexqual's technical model rates HLF "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of October 23, 2026 at 17:00 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 49.77 (neutral) |
| vs SMA50 | Above (USD 12.61) |
| MACD | 0.39 (positive) |
Analyst Ratings (HLF)
Wall Street analysts rate HLF "Hold" based on 4 analysts, with a mean price target of USD 17 (range USD 9–25), per Nexqual as of October 23, 2026 at 17:00 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 4 |
| Mean Target | USD 17 |
| High Target | USD 25 |
| Low Target | USD 9 |
| Buy / Hold / Sell | 3 / 0 / 1 |
Earnings (HLF)
| Next Earnings Date | 2026-11-02 |
|---|---|
| EPS Estimate | USD 0.62 |
| Revenue Estimate | $1.31B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.51 vs est 0.54 ▼ miss |
| 2026-03-31 | USD 0.64 vs est 0.61 ▲ beat |
| 2025-12-31 | USD 0.45 vs est 0.48 ▼ miss |
| 2025-09-30 | USD 0.5 vs est 0.46 ▲ beat |
Source: Nexqual, October 23, 2026 at 17:00 UTC.
Financials & Fundamentals (HLF)
| Total Revenue | $5.20B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +5.40% |
| Gross Margin | +77.70% |
| Operating Margin | +9.75% |
| Profit Margin | +3.16% |
| Current Ratio | 1.2 |
| Total Cash | $370.50M |
| Total Debt | $2.20B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | $322.30M (6.2% of revenue) |
Source: Nexqual, October 23, 2026 at 17:00 UTC.
Financial Health Score (HLF)
Nexqual rates Herbalife Ltd.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 17:00 UTC.
| Growth | Mixed — Revenue +0.9% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 78%, operating 10% (last 12 months) |
| Balance Sheet | Mixed — $371M cash and investments vs $2.02B debt (Jun 2026, SEC) |
| Cash Flow | Solid — FCF $322M (last 4 quarters to Jun 2026, SEC), 6% margin |
| Efficiency | Mixed — No data |
Ownership (HLF)
| Insider Ownership | +5.01% |
|---|---|
| Institutional Ownership | +100.98% |
| Shares Outstanding | 103.67M |
| Float | 84.67M |
| Short % of Float | +9.07% |
Source: Nexqual, October 23, 2026 at 17:00 UTC.
Leadership (HLF)
Herbalife Ltd. is led by Stephan Paulo Gratziani, Chief Executive Officer, per Nexqual as of October 23, 2026 at 17:00 UTC.
| Chief Executive Officer | Stephan Paulo Gratziani |
|---|---|
| Executive Chairman | Michael O. Johnson |
| President | Robert C. Levy |
| Chief Financial Officer | John G. DeSimone |
| Chief Operating Officer | Troy Hicks |
Major Backers & Investors (HLF)
Notable institutional backers of Herbalife Ltd. include BAUPOST GROUP LLC/MA, Route One Investment Company, L.P., Renaissance Technologies, according to Nexqual as of October 23, 2026 at 17:00 UTC.
Active Investors
| Investor | Stake |
|---|---|
| BAUPOST GROUP LLC/MA | 8.84% |
| Route One Investment Company, L.P. | 7.97% |
| Renaissance Technologies | 4.79% |
| Solel Partners LP | 2.72% |
| LSV Asset Management | 2.5% |
| Fidelity | 1.07% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 10.12% |
| BlackRock | 7.99% |
| Geode Capital | 3.31% |
| State Street | 2.43% |
Source: Nexqual, October 23, 2026 at 17:00 UTC.
From Herbalife Ltd.'s Latest SEC 10-K Filing (filed 2026-02-18)
Key Strengths & Strategy (as disclosed to the SEC)
- We take care in protecting the intellectual property rights of our proprietary formulas by restricting access to our formulas within the Company to those persons or departments that require access to them to perform their functions, and by requiring our finished goods suppliers and consultants to execute supply and non-disclosure agreements that contractually protect our intellectual property rights.
- Segmenting our Members allows us to more effectively communicate and market to each group, and provides us with better information about our Members.
- We leverage our technology infrastructure in order to maintain, protect, and enhance existing systems and develop new systems to keep pace with continuing changes in technology, evolving industry and regulatory standards, emerging data security risks, and changing user patterns and preferences.
Partnerships
- Our direct-selling business model enables us to grow our business with moderate investment in infrastructure and fixed costs.
Legal & Regulatory Risks (Item 1A, quoted)
- Our products are affected by extensive regulations and our failure or our Members' failure to comply with any regulations could lead to significant penalties or claims, which could materially harm our financial condition and operating results.
- Our network marketing program is subject to extensive regulation and scrutiny and any failure to comply, or alteration to our compensation practices in order to comply, with these regulations could materially harm our business, financial condition, and operating results.
- We are subject to the Consent Order with the FTC, the effects of which, or any failure to comply therewith, could materially harm our business, financial condition, and operating results.
- Our actual or perceived failure to comply with privacy, artificial intelligence (AI), and data protection laws, rules, and regulations could materially harm our business, financial condition, and operating results.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| INGR | Ingredion Incorporated | USD 96.28 | ▼ 0.93% |
| CPB | The Campbell's Company | USD 20.55 | ▼ 3.34% |
| PPC | Pilgrim's Pride Corporation | USD 27.62 | ▼ 1.69% |
| CAG | ConAgra Brands, Inc. | USD 14.8 | ▼ 1.79% |
| SFD | Smithfield Foods, Inc. | USD 18.44 | ▼ 1.99% |
| LW | Lamb Weston Holdings, Inc. | USD 54.35 | ▼ 1.51% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 17:00 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt